771590007: Erenumab (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance)\Erenumab

\Drug or medicament (substance)\Monoclonal antibody\Erenumab

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Erenumab

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Erenumab

\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Erenumab
\Biological substance\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Erenumab

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3706918013 Erenumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3706919017 Erenumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4211881000052110 erenumab sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Erenumab	Is a	Monoclonal antibody	true	Inferred relationship	Some
Erenumab	Has disposition (attribute)	Calcitonin gene-related peptide receptor antagonist (disposition)	true	Inferred relationship	Some
Erenumab	Is a	Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Erenumab-containing product	Has active ingredient	True	Erenumab	Inferred relationship	Some	1
Erenumab-containing product in parenteral dose form	Has active ingredient	True	Erenumab	Inferred relationship	Some	1
Product containing only erenumab (medicinal product)	Has active ingredient	True	Erenumab	Inferred relationship	Some	1
Erenumab only product in parenteral dose form	Has active ingredient	True	Erenumab	Inferred relationship	Some	1
Erenumab 70 mg/mL solution for injection	Has precise active ingredient	True	Erenumab	Inferred relationship	Some	1
Erenumab 70 mg/mL solution for injection	Has basis of strength substance (attribute)	True	Erenumab	Inferred relationship	Some	1
Product containing precisely erenumab 140 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has precise active ingredient	True	Erenumab	Inferred relationship	Some	1
Product containing precisely erenumab 140 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has basis of strength substance (attribute)	True	Erenumab	Inferred relationship	Some	1

This concept is not in any reference sets